Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Unknown 4Completed 4Active not recruiting 3Recruiting 2Terminated 1Not yet recruiting 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 20Thoracic 9Other solid neoplasm 9Breast 7Gynecologic 5Sarcoma 3Head & Neck 3Plasma cell 2Other hematologic neoplasm 2Tumor-Agnostic 1Lymphoid 1Genitourinary 1Endocrine 1Dermatologic 1

Conditions

Sarcoma 1Melanoma 1

Interventions

Nivolumab 7pembrolizumab 4Ipilimumab 4cemiplimab 3Specimen Handling 3relatlimab 2Watchful Waiting 2Standard of Care 2Prednisone 2Phototherapy 2Photochemotherapy 2Melphalan 2Magnetic Resonance Spectroscopy 2Interleukin-2 2Dermoscopy 2Cryotherapy 2Carboplatin 2vedolizumab 1trametinib 1toripalimab 1tirbanibulin 1sulforaphane 1gadopiclenol 1famitinib 1decitabine and cedazuridine drug combination 1daromun 1calcipotriene 1anlotinib 1X-Rays 1Vitamin D 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Injections × Dermatologic × Clear all
NCT06500091 2024-07-15

TQB2916 Injection Combined With Chemotherapy or Penpulimab Injection in the Treatment of Solid Tumors

Chia Tai Tianqing Pharmaceutical Group Co., Ltd.

Phase 2 Not yet recruiting
54 enrolled
DermatologicSarcoma

Melanoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡